Sofia Med AD Sustainability Profile
Sofia Med AD, a prominent player in the healthcare industry, is headquartered in Bulgaria (BG) and operates extensively across the region. Founded in 1995, the company has established itself as a leader in the production and distribution of medical devices and consumables, catering to hospitals and healthcare facilities. With a diverse portfolio that includes innovative surgical instruments and high-quality medical supplies, Sofia Med AD is recognised for its commitment to excellence and reliability. The company’s unique approach combines advanced technology with rigorous quality control, ensuring that its products meet the highest standards. Over the years, Sofia Med AD has achieved significant milestones, solidifying its market position as a trusted partner in healthcare. Its dedication to customer satisfaction and continuous improvement has earned it a reputation for excellence in the medical sector.
DitchCarbon Score
How does Sofia Med AD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sofia Med AD's score of 21 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sofia Med AD, headquartered in Bulgaria (BG), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Viohalco S.A., which may influence its climate commitments and performance metrics. As of now, Sofia Med AD has not established any documented reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). This lack of specific commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of direct emissions data, it is essential for Sofia Med AD to consider adopting industry-standard climate initiatives and setting measurable targets to enhance its sustainability profile. This approach would not only align with global climate goals but also improve its operational resilience in an increasingly eco-conscious market.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 133,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 149,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Sofia Med AD's Industry?
How Carbon Intensive is Sofia Med AD's Location?
Sofia Med AD's Scope 3 Categories Breakdown
Sofia Med AD's Scope 3 emissions, which increased by 6% last year and increased by approximately 6% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 57% of Scope 3 emissions.
Top Scope 3 Categories
Sofia Med AD's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sofia Med AD has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
